Our Pricing

Wegovy Weight Loss Prescription Online UK

Published on: June 03, 2026

Looking for a wegovy weight loss prescription online UK service? Cured Pharmacy offers transparent pricing from £79.00 with a free clinical assessment completed in under three minutes by UK-registered prescribers. Our GPhC-registered pharmacy dispenses only genuine UK-licensed Wegovy pens with discreet, next-day delivery across the UK.

How Wegovy (Semaglutide) Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics the natural hormone GLP-1, which regulates appetite by acting on areas of the brain that control hunger and food intake.

In the landmark STEP 1 trial, participants using semaglutide 2.4 mg weekly achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The medication works by slowing gastric emptying, reducing appetite, and improving glycaemic control, helping patients achieve sustainable weight loss when combined with lifestyle modifications.

Clinical trials demonstrate that semaglutide may also improve cardiovascular risk markers, including reductions in waist circumference, blood pressure, and HbA1c levels in patients with type 2 diabetes [2]. These effects contribute to the overall metabolic benefits observed in long-term weight management programmes.

Wegovy Dosing Schedule and Treatment Journey

Wegovy follows a structured dose-escalation protocol designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes. Treatment begins with 0.25 mg once weekly for four weeks, gradually increasing every four weeks through 0.5 mg, 1 mg, and 1.7 mg, before reaching the maintenance dose of 2.4 mg weekly [3].

This gradual titration allows your body to adapt to the medication, significantly reducing the likelihood of nausea and vomiting — the most commonly reported side effects during initiation. Most patients reach the full maintenance dose within 16 to 20 weeks of starting treatment, subject to individual tolerability and prescriber guidance.

Your UK prescriber at Cured Pharmacy will monitor your progress throughout the dose-escalation phase, adjusting the schedule if needed based on your response and any side effects experienced. Consistent weekly administration on the same day optimises therapeutic outcomes and helps establish a sustainable routine.

What to Expect During Your First Month

During the initial four weeks on the 0.25 mg starter dose, many patients notice a gradual reduction in appetite and food cravings. Whilst significant weight loss typically occurs at higher doses, this introductory phase helps your body adjust to semaglutide's effects. Mild nausea is common but usually subsides within the first few weeks as tolerance develops.

Wegovy Weight Loss Prescription Online UK: The Clinical Assessment Process

All Wegovy prescriptions at Cured Pharmacy require a clinical assessment by a UK-registered prescriber, completed entirely online in under three minutes. The consultation evaluates your medical history, current medications, weight loss goals, and any contraindications to ensure Wegovy is safe and appropriate for you.

Our prescribers assess eligibility based on NICE guidelines and MHRA licensing criteria, including BMI thresholds and the presence of weight-related health conditions such as hypertension, type 2 diabetes, or dyslipidaemia. You'll be asked about previous weight loss attempts, current eating patterns, and any history of pancreatitis, thyroid disorders, or eating disorders.

Once approved, your prescription is issued electronically and sent directly to our GPhC-registered pharmacy (9012511), where superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees dispensing. Your Wegovy pens are dispatched in 100% discreet packaging, typically arriving the next working day via tracked courier.

Who Can Use Wegovy?

Wegovy is licensed for adults aged 18 and over with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity. It is not suitable for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or those with severe gastrointestinal disease. Your prescriber will review all eligibility criteria during your assessment.

Common Side Effects and How to Manage Them

The most frequently reported side effects of Wegovy are gastrointestinal, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [3]. These symptoms are typically mild to moderate, occurring most commonly during dose escalation, and tend to diminish as your body adapts to the medication.

To minimise nausea, eat smaller, more frequent meals, avoid high-fat or spicy foods, and stay well-hydrated throughout the day. Injecting Wegovy at the same time each week and rotating injection sites (abdomen, thigh, or upper arm) can also improve tolerability. If side effects persist or become severe, contact your prescriber — they may recommend slowing the dose escalation or temporarily maintaining your current dose.

Rare but serious side effects include pancreatitis, gallbladder disease, and hypoglycaemia (particularly in patients taking other glucose-lowering medications). Seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, or signs of an allergic reaction such as rash, swelling, or difficulty breathing [3].

Wegovy vs Other Weight Loss Treatments Available in the UK

Wegovy is one of several prescription weight loss treatments licensed in the UK, each with distinct mechanisms, dosing schedules, and clinical profiles. Understanding these differences helps you and your prescriber select the most appropriate option based on your individual needs, preferences, and medical history.

Semaglutide-based treatments like Wegovy offer once-weekly convenience and robust clinical trial data demonstrating significant weight loss. Alternative GLP-1 receptor agonists, dual-action medications, and lipase inhibitors provide additional options for patients who may not tolerate or respond optimally to semaglutide.

Your UK prescriber will consider factors including your BMI, comorbidities, previous treatment responses, injection tolerance, and cost when recommending a treatment plan. All prescription weight loss medications require ongoing lifestyle modifications — including dietary changes and increased physical activity — to achieve and maintain optimal outcomes.

Choosing Between Injectable and Oral Options

Injectable treatments like Wegovy typically demonstrate superior weight loss outcomes in clinical trials compared to oral medications, though they require weekly self-administration via subcutaneous injection. Oral options may suit patients with needle phobia or those preferring tablet-based therapy, subject to prescriber assessment and individual suitability.

Why Choose Cured Pharmacy for Your Wegovy Prescription

Cured Pharmacy is a fully registered UK online pharmacy (GPhC 9012511) offering transparent upfront pricing, with Wegovy available from £79.00 — lower than typical market rates. Unlike services that hide costs until after consultation, we display all prices clearly before you begin your clinical assessment, ensuring complete transparency.

Our UK-registered prescribers complete consultations in under three minutes, with most patients receiving approval within hours. We dispense only genuine UK-licensed medicines sourced directly from licensed wholesalers, never grey-market imports. Superintendent pharmacist Tarun Kumar (GPhC 2233073) personally oversees quality assurance and clinical governance across all prescriptions.

Every order includes free online consultation, discreet packaging with no external pharmacy branding, and next-day tracked delivery across the UK. Our clinical team remains available via phone (+44 116 4646009) for ongoing support throughout your weight loss journey, ensuring you receive expert guidance at every stage of treatment.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Davies, M., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0 [accessed 13 August 2026]
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
4. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
5. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
6. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.